PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET ANALYSIS

Porcine Reproductive and Respiratory Syndrome Vaccine Market, By Product Type (Modified Live Virus Vaccine, Inactivated Vaccine, and Subunit Vaccines), By Route of Administration (Intramuscular and Intradermal), By Virus Genotype (Type I and Type II), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlooks, and Opportunity Analysis, 2022-2028

To Be Published : Oct 2024
Code : CMI3285
Formats :
Excel and PDF
Industry : Biotechnology

Porcine Reproductive And Respiratory Syndrome Vaccine MarketSize and Trends

Global Porcine Reproductive and Respiratory Syndrome Vaccine Market Dynamics

An increasing demand for pork meat is expected to propel the market growth over the forecast period. According to the U.S Department of Agriculture - Foreign Agricultural Service (USDA – FAS), 2017, among the total meat consumption nearly 40.4% of pork meat is consumed globally.

Moreover, significant economic losses to swine producers caused by the porcine reproductive and respiratory virus is expected to propel the market growth. For instance, according to the statistics presented in the North American PRRS Symposium held in November 2019, an around 62% out of total economic loss was reported in the pork meat production market, which is US$ 581 million, has occurred in the growing period of the pigs due to the porcine reproductive and respiratory virus.